Screener
Revolution Medicines, Inc. RVMD Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s retained earnings?
- Revolution Medicines, Inc. (RVMD) reported retained earnings of -$3.32B in Q1 2026.
- How has Revolution Medicines, Inc.'s retained earnings changed year-over-year?
- Revolution Medicines, Inc.'s retained earnings decreased by 70.3% year-over-year, from -$1.95B to -$3.32B.
- What is the long-term trend for Revolution Medicines, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s retained earnings has grown at a 61.0% compound annual growth rate (CAGR), from -$265.55M to -$2.87B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Revolution Medicines, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude